Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
Haematologica
|
April 9, 2021
Circulating histones play a central role in COVID-19-associated coagulopathy and mortality
Rebecca J Shaw, Simon T Abrams, James Austin, et al.
Brain & Development
|
December 12, 2001
Neuroimaging studies in Rett syndrome
S Naidu, W E Kaufmann, M T Abrams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 10, 2009
Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment
Marc T Abrams, Martin L Koser, Jessica Seitzer, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2001
Diaryl ether inhibitors of farnesyl-protein transferase
S C Mactough, S J Desolms, A W Shaw, et al.
RNA (New York, N.Y.)
|
October 14, 2010
Quantitative evaluation of siRNA delivery in vivo
Yi Pei, Paula J Hancock, Hangchun Zhang, et al.
Molecular Cancer Therapeutics
|
July 9, 2016
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin
Shanthi Ganesh, Martin L Koser, Wendy A Cyr, et al.
The Journal of Biological Chemistry
|
March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors
H E Huber, R G Robinson, A Watkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I
J M Bergman, M T Abrams, J P Davide, et al.
Plos One
|
June 18, 2025
Group antenatal care positively transforms the care experience: Results of an effectiveness trial in Malawi
Crystal L Patil, Kathleen F Norr, Esnath Kapito, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2002
The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases
Thomas J Tucker, Marc T Abrams, Carolyn A Buser, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
Haematologica
|
April 9, 2021
Circulating histones play a central role in COVID-19-associated coagulopathy and mortality
Rebecca J Shaw, Simon T Abrams, James Austin, et al.
Brain & Development
|
December 12, 2001
Neuroimaging studies in Rett syndrome
S Naidu, W E Kaufmann, M T Abrams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 10, 2009
Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment
Marc T Abrams, Martin L Koser, Jessica Seitzer, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2001
Diaryl ether inhibitors of farnesyl-protein transferase
S C Mactough, S J Desolms, A W Shaw, et al.
RNA (New York, N.Y.)
|
October 14, 2010
Quantitative evaluation of siRNA delivery in vivo
Yi Pei, Paula J Hancock, Hangchun Zhang, et al.
Molecular Cancer Therapeutics
|
July 9, 2016
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin
Shanthi Ganesh, Martin L Koser, Wendy A Cyr, et al.
The Journal of Biological Chemistry
|
March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors
H E Huber, R G Robinson, A Watkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2001
Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I
J M Bergman, M T Abrams, J P Davide, et al.
Plos One
|
June 18, 2025
Group antenatal care positively transforms the care experience: Results of an effectiveness trial in Malawi
Crystal L Patil, Kathleen F Norr, Esnath Kapito, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2002
The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases
Thomas J Tucker, Marc T Abrams, Carolyn A Buser, et al.
Page
of 15